Can pre-treatment PSA reliably serve as a predictor of clinical failure and prostate cancer related death?

被引：0
|
作者：
Mayer, R [1 ]
Quehenberger, F [1 ]
Feigl, GC [1 ]
Pummer, K [1 ]
Langsenlehner, U [1 ]
Hackl, A [1 ]
机构：
[1] Graz Univ, Sch Med, Graz, Austria
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：369 / 369
页数：1
相关论文
共 50 条
  • [1] Body weight status predicts pre-treatment risk of PSA failure in men with clinically localized prostate cancer
    Freeman, Vincent L.
    Flanigan, Robert C.
    Hollowell, Courtney M.
    Branch, Jeffrey
    Deane, Leslie
    Quek, Marcus
    Vidal, Patricia P.
    Friedman, Nicholas
    Cintron, Daisy
    Dabbous, Firas
    Millbrandt, Linda
    Garabedian, Anne
    Cleofe, Jasmine
    Gomez, Sandra L.
    [J]. CANCER RESEARCH, 2012, 72
  • [2] Can progression of prostate cancer be predicted by pre-treatment parameters?
    Carter, HB
    Partin, AW
    [J]. RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 215 - 224
  • [3] Pre-treatment PSA level does not predict early death from prostate cancer following external beam therapy
    McLaughlin, PW
    Wang, S
    Sandler, HM
    [J]. RADIOLOGY, 2000, 217 : 265 - 266
  • [4] Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA
    Merrick, Gregory S.
    Galbreath, Robert W.
    Butler, Wayne M.
    Fiano, Ryan
    Adamovich, Edward
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (04) : 297 - 303
  • [5] Pre-treatment PSA velocity and risk of cancer progression following radiation therapy for prostate cancer
    Eggener, SE
    Roehl, KA
    Suarez, BK
    Catalona, WJ
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 311 - 311
  • [6] Pre-treatment PSA velocity and the probability of detecting high-grade prostate cancer
    Krejcarek, S. C.
    Chen, M.
    Renshaw, A.
    Loffredo, M.
    Sussman, B.
    D'Amico, A. V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S345 - S345
  • [7] Outcome analysis of prostate cancer patients with pre-treatment PSA greater than 50 ng/ml
    Wiebe, Ericka
    Rodrigues, George
    Lock, Michael
    D'Souza, David
    Stitt, Larry
    [J]. CANADIAN JOURNAL OF UROLOGY, 2008, 15 (03) : 4078 - 4083
  • [8] Pre-treatment red blood cell distribution width as a predictor of clinically significant prostate cancer
    Huang, Tian-bao
    Zhu, Liang-yong
    Zhou, Guang-chen
    Ding, Xue-fei
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (09) : 1765 - 1771
  • [9] Pre-treatment red blood cell distribution width as a predictor of clinically significant prostate cancer
    Tian-bao Huang
    Liang-yong Zhu
    Guang-chen Zhou
    Xue-fei Ding
    [J]. International Urology and Nephrology, 2021, 53 : 1765 - 1771
  • [10] Pre-treatment PSA velocity as a predictor of disease outcome following radical radiation therapy
    Palma, D.
    Tyldesley, S.
    Blood, P.
    Liu, M.
    Duncan, G.
    Morris, J.
    Pickles, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S36 - S36
12345